COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Multicenter Interventional Lymphangioleiomyomatosis (LAM) Early Disease Trial (MILED)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03150914
Recruitment Status : Recruiting
First Posted : May 12, 2017
Last Update Posted : April 29, 2020
National Heart, Lung, and Blood Institute (NHLBI)
National Center for Advancing Translational Science (NCATS)
The LAM Foundation
Information provided by (Responsible Party):
Francis McCormack, University of Cincinnati

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : June 30, 2023
Estimated Study Completion Date : June 30, 2023